KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Change in Inventory (2016 - 2025)

Zimmer Biomet Holdings has reported Change in Inventory over the past 17 years, most recently at -$184.4 million for Q4 2025.

  • Quarterly results put Change in Inventory at -$184.4 million for Q4 2025, down 109.78% from a year ago — trailing twelve months through Dec 2025 was -$98.2 million (down 96.79% YoY), and the annual figure for FY2025 was -$98.2 million, down 96.79%.
  • Change in Inventory for Q4 2025 was -$184.4 million at Zimmer Biomet Holdings, down from $46.0 million in the prior quarter.
  • Over the last five years, Change in Inventory for ZBH hit a ceiling of $94.2 million in Q1 2023 and a floor of -$184.4 million in Q4 2025.
  • Median Change in Inventory over the past 5 years was $19.0 million (2022), compared with a mean of $8.8 million.
  • Biggest five-year swings in Change in Inventory: surged 15600.0% in 2023 and later crashed 411.7% in 2024.
  • Zimmer Biomet Holdings' Change in Inventory stood at -$87.2 million in 2021, then skyrocketed by 113.88% to $12.1 million in 2022, then skyrocketed by 133.06% to $28.2 million in 2023, then crashed by 411.7% to -$87.9 million in 2024, then crashed by 109.78% to -$184.4 million in 2025.
  • The last three reported values for Change in Inventory were -$184.4 million (Q4 2025), $46.0 million (Q3 2025), and $37.2 million (Q2 2025) per Business Quant data.